<!DOCTYPE html>
<html lang="en">
<head>
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-EPQ9202NVY"></script>
<script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());
      
      //- gtag('config', 'UA-71059016-1');
      gtag('config', 'G-EPQ9202NVY');
      
    </script>
<title>PDB-101: Molecule of the Month: Proteins and Nanoparticles</title>
<meta charset="utf-8"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<meta content="PDB101: Molecule of the Month: Proteins and Nanoparticles" property="og:title"/>
<meta content="Nanotech scientists are designing new ways to combine proteins and nanoparticles " property="og:description"/>
<meta content="https://cdn.rcsb.org/pdb101/motm/222/221-Proteins_and_Nanoparticles-5et3_motm.jpg" property="og:image"/>
<meta content="http://pdb101.rcsb.org/motm/222" property="og:url"/>
<meta content="RCSB: PDB-101" property="og:site_name"/>
<meta content="summary" name="twitter:card"/>
<meta content="PDB101: Molecule of the Month: Proteins and Nanoparticles" name="twitter:title"/>
<meta content="Nanotech scientists are designing new ways to combine proteins and nanoparticles " name="twitter:description"/>
<meta content="https://cdn.rcsb.org/pdb101/motm/222/221-Proteins_and_Nanoparticles-5et3_motm.jpg" name="twitter:image"/>
<meta content="Nanotech scientists are designing new ways to combine proteins and nanoparticles " name="description"/>
<meta content="nanotechnology,nanoparticle,biosensor,fullerene,buckyball,calixarene,MRI,medical diagnostics,protein engineering,protein design,5et3,4prq,5oeh,3nkx,3cyu" name="keywords"/>
<!-- associate with our Google Analytics-->
<meta content="A8M31jAX8SUgQYzbnF5r-wgykna2i5Hp4J9fziVD9Sg" name="google-site-verification"/>
<link href="https://cdn.rcsb.org/pdb101/common/jquery-ui-1.11.4/jquery-ui.min.css" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/javascript/bootstrap/latest/css/bootstrap.min.css" rel="stylesheet"/>
<link href="https://pdb101.rcsb.org/ekko-lightbox/ekko-lightbox.css" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/javascript/fontawesome/fontawesome-free-6.7.2/css/all.min.css" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/javascript/timeline3/css/timeline.css" rel="stylesheet"/>
<link href="https://pdb101.rcsb.org/css/style.css?v=20171201" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/jira-feedback/css/jira-fdbck.css" rel="stylesheet"/><!--[if lt IE 9]>
    <script src="https://oss.maxcdn.com/html5shiv/3.7.2/html5shiv.min.js"></script>
    <script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script><![endif]-->
<script src="https://cdn.rcsb.org/javascript/jquery/jquery-2.2.4.min.js"></script>
<script src="https://cdn.rcsb.org/pdb101/common/jquery-ui-1.11.4/jquery-ui.min.js"></script>
<script src="https://cdn.rcsb.org/javascript/bootstrap/latest/js/bootstrap.min.js"></script>
<script src="https://pdb101.rcsb.org/ekko-lightbox/ekko-lightbox.min.js"></script>
<script src="https://pdb101.rcsb.org/js/common.js"></script>
<script src="https://cdn.rcsb.org/jira-feedback/js/jira-fdbck.min.js"></script>
</head>
<body>
<div class="container" id="main_content">
<style>
          #jmolTabs {
              margin: 20px 0;
          }
          
          .motm-hr {
              color: #ccc;
              background-color: #ccc;
              height: 1px;
              border: none;
          }
          
          .jmolText {
              font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
              font-size: 14px;
          }
          
          /* over-write bootstrap values */
          .nav-tabs {
              background: linear-gradient(to bottom, #fff, #ddd);
          }
          
          .tab-content {
              border-left: 1px solid #ddd;
              border-right: 1px solid #ddd;
              border-bottom: 1px solid #ddd;
              border-bottom-right-radius: 4px;
              border-bottom-left-radius: 4px;
              padding: 15px;
          }
          .nav-tabs > li.active > a, .nav-tabs > li.active > a:hover, .nav-tabs > li.active > a:focus {
              background-color: #fff;
              color: #333;
          }
          
          .tab-pane {
              padding-bottom: 10px;
          }
          
          #tabs-1 img {
              cursor: pointer;
          }
          
          .fa-cloud-download { margin-left:10px; }
          /* customize div.img-with-caption in style.css */
          div.img-with-caption {
              max-width: 50%;
              margin-top: 10px;
          }
          div.float-right { float: right; margin-left: 20px; }
          div.float-left { float: left; margin-right: 20px; }
          
          .link-motm {
              background-color: #d9ebd294;
              padding: 10px;
              border-radius: 4px;
              border: 1px solid #bcedbd;
              overflow-wrap: break-word;
          }
          div.jmol-image { margin-bottom: 5px; }
          
        </style>
<script>
          // jmol script
          var jmolLoaded = false
          function loadIframe() {
              if (jmolLoaded == false) {
                  var src = '/motm/jmol/?id=' + 222
                  console.log('src=' + src)
                  $("#iframe").attr('src', src)
                  jmolLoaded = true
              }
          }
          function clickJmolTab() {
              $('#jmol-tab').trigger('click')
          }
          
          // jmol script for legacy motms with multiple jmols
          var jmols = [];
          function loadIframeById(jmolId) {
              var jmol = jmols[jmolId - 1]
              if (jmol.loaded == false) {
                  var src = '/motm/jmol/?id=' + 222 + '&jmolId=' + jmolId
                  $("#iframe_" + jmolId).attr('src', src)
                  jmol.loaded = true
              }
          }
          function clickJmolTab(i) {
              var j = i + 1
              $('#jmol-tab-' + j).trigger('click')
          }
          
        </script>
<div id="sub-navbar">
<div class="row hidden-print">
<div class="col-xs-12 col-sm-6 sub-navbar">
<h4>Molecule of the Month</h4>
</div>
<div class="col-xs-12 col-sm-6 text-right sub-navbar">
<table>
<tr>
<td onclick='location.href="/motm/motm-by-category"'>By Category</td>
<td onclick='location.href="/motm/motm-by-date"'>By Date</td>
<td onclick='location.href="/motm/motm-by-title"'>By Title</td>
</tr>
</table>
</div>
</div>
</div>
<div data-elastic-include="">
<h1>Molecule of the Month: Proteins and Nanoparticles</h1>
<p><i>Nanotech scientists are designing new ways to combine proteins and nanoparticles </i></p>
<div>
<div class="img-with-caption float-right">
<div class="img-with-caption-table"><img alt="Crystal lattice of COP (blue, with tyrosine in green) with fullerenes (white)." class="img-responsive" src="https://cdn.rcsb.org/pdb101/motm/222/221-Proteins_and_Nanoparticles-5et3_motm.jpg"/>
<div class="img-caption">
<div style="margin-bottom:10px;"><i>Crystal lattice of COP (blue, with tyrosine in green) with fullerenes (white).</i></div><a href="https://cdn.rcsb.org/pdb101/motm/222/221-Proteins_and_Nanoparticles-5et3_motm.tif"><small>Download high quality TIFF image<span class="fa fa-cloud-download"></span></small></a>
</div>
</div>
</div>
<div>Pure carbon is found in many forms: a perfect three-dimensional lattice of carbon atoms provides the strength of diamonds, and two-dimensional sheets of carbon atoms provide the smooth, slippery feeling of graphite. Researchers discovered a new form of carbon in 1985, with 60 atoms arranged to form a symmetrical hollow sphere. Because of their similarity to the geodesic domes designed by Buckminster Fuller, these new molecules were called “fullerenes”. Like diamond and graphite, this new form of carbon has its own properties: fullerenes, and tube-shaped variants called nanotubes, can conduct electricity or heat, but at a much smaller scale than typical copper wires. Because of their perfect, symmetrical shape and surprising properties, fullerenes have become a favorite subject in nanotechnology. However, fullerenes have a major drawback for life sciences applications: they are insoluble in water. Scientists are now designing new interactions between proteins and fullerenes (and other nanoparticles) for novel applications in nanotechnology and medicine.</div>
<h4>Designing a Fullerene Binder</h4>
<div>To design a protein that binds to nanotubes, researchers noticed that the geometry of an ideal alpha helix matches the honeycomb geometry of graphene. So, they positioned alanine amino acids along an alpha helix to match the center of the repeating hexagonal unit of the graphene sheet. Then, they engineered new interactions based on a designed protein that forms a four-helix bundle, so that the helices associate side-by-side around the nanotube. When they made these peptides, they found that they bind to nanotubes, just as they were designed to do. Serendipitously, they also found that a tyrosine amino acid on the peptide flips out to form a little cage that can also enclose fullerenes.</div>
<h4>Conducting Complex</h4>
<div>This designed alpha helix, called COP (C60-organizing peptide), forms a crystalline complex when mixed with fullerenes. PDB entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=5et3" target="_blank">5et3</a> shows how two neighboring COP peptides cup the fullerenes with their tyrosine amino acids, forming a large superstructure with many COPs and fullerenes in defined places. When tested, fullerenes or COP proteins by themselves are not conductive, but this 3D lattice of perfectly-placed nanoparticles and proteins does conduct electricity.</div>
</div>
<div class="clearfix"></div>
<hr class="motm-hr"/>
<div>
<div class="img-with-caption float-left">
<div class="img-with-caption-table"><img alt="Calixarene molecules (in atomic colors) bind to lysozyme (blue) and cause it to aggregate into tetramers and higher-order structures." class="img-responsive" src="https://cdn.rcsb.org/pdb101/motm/222/221-Proteins_and_Nanoparticles-4prq.jpg"/>
<div class="img-caption">
<div style="margin-bottom:10px;"><i>Calixarene molecules (in atomic colors) bind to lysozyme (blue) and cause it to aggregate into tetramers and higher-order structures.</i></div><a href="https://cdn.rcsb.org/pdb101/motm/222/221-Proteins_and_Nanoparticles-4prq.tif"><small>Download high quality TIFF image<span class="fa fa-cloud-download"></span></small></a>
</div>
</div>
</div>
<h4>Cupping Calixarenes </h4>
<div>Researchers are also designing nanoparticles for specific tasks, and combining them with proteins. Calixarenes are composed of four linked benzene rings. Larger chemical groups are connected to one side of the benzene ring, forcing it to open up and form a cup. If designed correctly, with the proper chemical groups around the rim, calixarenes can selectively bind (or “host”) a particular charged or neutral molecule. They were originally designed to bind to small molecules and ions, but researchers have also repurposed calixarenes to bind protein surfaces. The structure shown here is <a href="https://pdb101.rcsb.org/motm/9">lysozyme</a> with calixarenes bound to its surface (pdb entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=4prq" target="_blank">4prq</a>). In this structure calixarenes are acting in two different ways. Half of them recognize and “camouflage” the charge of an arginine amino acid on the lysozyme surface, and the remaining ones are hosting PEG (a compound used in the crystallization of proteins) and act like a big gluey ball to fill spaces between the proteins. Through these interactions, this calixarene promotes assembly of lysozyme to form tetramers, which further assemble into long repeating chains. Scientists are exploring hosting molecules like calixarenes to promote (or reduce) protein aggregation and assist with protein crystallization.</div>
</div>
<div class="clearfix"></div>
<hr class="motm-hr"/>
<div>
<div class="img-with-caption float-left">
<div class="img-with-caption-table"><img alt="(Left) Signaling protein 14-3-3 (blue) bound to peptides (magenta) from its partner protein C-RAF. (Right) Molecular tweezers (atomic colors) bind to a lysine (bright blue) and block the peptide-binding site. " class="img-responsive" src="https://cdn.rcsb.org/pdb101/motm/222/221-Proteins_and_Nanoparticles-5oeh_3nkx.jpg"/>
<div class="img-caption">
<div style="margin-bottom:10px;"><i>(Left) Signaling protein 14-3-3 (blue) bound to peptides (magenta) from its partner protein C-RAF. (Right) Molecular tweezers (atomic colors) bind to a lysine (bright blue) and block the peptide-binding site. </i></div><a href="https://cdn.rcsb.org/pdb101/motm/222/221-Proteins_and_Nanoparticles-5oeh_3nkx.tif"><small>Download high quality TIFF image<span class="fa fa-cloud-download"></span></small></a>
</div>
</div>
</div>
<h4>Protein Modulators</h4>
<div>Researchers are also designing nanoparticles to bind to specific amino acids and modulate the function of proteins. For example, a C-shaped “molecular tweezer” has been designed with two negatively-charged groups, making it both water-soluble and specific for binding to lysine and arginine. Researchers found that this nanoparticle inhibits signaling by the 14-3-3 protein. In the structure (pdb entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=5oeh" target="_blank">5oeh</a>), the tweezer binds to a single surface-exposed lysine. As seen in PDB entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=3nkx" target="_blank">3nkx</a>), this lysine is near the binding site for other signaling proteins such as C-RAF, suggesting that the tweezer acts by blocking the binding or changing the dynamics of these partner proteins.</div>
</div>
<div class="clearfix"></div>
<hr class="motm-hr"/>
<h4>Exploring the Structure</h4>
<div class="jmolText" id="jmolTabs">
<ul class="nav nav-tabs">
<li class="active"><a data-toggle="tab" href="#tabs-1">Image</a></li>
<li><a data-toggle="tab" href="#tabs-2" id="jmol-tab" onclick="loadIframe();">JSmol</a></li>
</ul>
<div class="tab-content">
<div class="tab-pane active" id="tabs-1">
<h5>Biosensor for MRI </h5>
<div class="img-with-caption float-left" style="margin-top:0;"><img class="img-responsive" onclick="clickJmolTab();" src="https://cdn.rcsb.org/pdb101/motm/222/221-Proteins_and_Nanoparticles-3cyu_JSmol.jpg"/></div>
<p>An isotope of xenon (129-Xe) is used as a contrast agent for magnetic resonance imaging (MRI) in medical diagnostic testing, both as a gas to image airspaces in the lung, and dissolved in body fluids to image the bloodstream and tissues. Designed cryptophanes are being developed as a way to target the xenon to specific proteins. Cryptophanes are hollow shells, but with openings on the sides that allow entry and exit of host molecules. The cryptophane shown here is the right size for a single xenon atom (shown in magenta), and is coupled to a specific inhibitor of carbonic anhydrase, which recognizes a zinc atom (turquoise) in the enzyme active site. Upon binding of the designed cryptophane to the target protein, xenon displays a distinctive MRI spectrum. To explore the structure of this cryptophane bound to human carbonic anhydrase II (PDB entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=3cyu" target="_blank">3cyu</a>), click on the image for an interactive JSmol.</p>
<div class="clearfix"></div>
</div>
<div class="tab-pane" id="tabs-2">
<iframe frameborder="0" id="iframe" marginheight="0" marginwidth="0" scrolling="yes" width="100%"></iframe>
</div>
</div>
</div>
<div class="row">
<div class="col-xs-12 col-sm-12 col-md-6">
<h4>Topics for Further Discussion</h4>
<ol>
<li>Recognition of host molecule by a protein can also occur with no charged residues. For example, try looking at the insulin amino acids recognized by the inner core of cucurbituril, a molecule with a shape of a pumpkin (pdb entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=3q6e" target="_blank">3q6e</a>—be sure to look at the second biological assembly, since the first one doesn't include the nanoparticle).</li>
<li>To explore the structure and properties of the nanoparticles themselves, try looking at the entries in the Ligand Depot, such as the one for <a href="http://www.rcsb.org/ligand/60C"> fullerene</a> or the <a href="https://www.rcsb.org/ligand/9SZ"> molecular tweezer.</a></li>
</ol>
<div data-elastic-exclude="">
<div class="col-xs-12 link-motm">
<h4>Related PDB-101 Resources</h4>
<ul>
<li>Browse <a href="https://pdb101.rcsb.org/browse/nanotechnology">Nanotechnology</a></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-12 col-md-6" style="border-left:1px dashed #ddd;">
<h4>References</h4>
<ol>
<li>S van Dun, C Ottmann, LG Milroy &amp; L Brunsveld (2017) Supramolecular chemistry targeting proteins. Journal of the American Chemical Society 139, 13960-13968.</li>
<li>5et3: KH Kim, DK Ko, YT Kim, NH Kim, J Paul, SQ Zhang, CB Murray, R Acharya, WF DeGrado, YH Kim &amp; G Grigoryan (2016) Protein-directed self-assembly of a fullerene crystal. Nature Communications 7, 11429-11429.</li>
<li>4prq: RE McGovern, AA McCarthy &amp; PB Crowley (2014) Protein assembly mediated by sulfonatocalix[4]arene. Chemical Communications 50, 10412-10415.</li>
<li>5oeh: D Bier, R Rose, K Bravo-Rodriguez, M Bartel, JM Ramirez-Anguita, S Dutt, C Wilch, FG Klärner, E Sanchez-Garcia, T Schrader &amp; C Ottmann (2013) Molecular tweezers modulate 14-3-3 protein-protein interactions. Nature Chemistry 5, 234-239.</li>
<li>3nkx: M Molzan, B Schumacher, C Ottmann, A Baljuls, L Polzien, M Weyand, P Thiel, R Rose, M Rose, P Kuhenne, M Kaiser, UR Rapp, J Kuhlmann &amp; C Ottmann (2010) Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling. Molecular Cell Biology 30, 4698-4711. </li>
<li>3q6e: JM Chinai, AB Taylor, LM Ryno, ND Hargreaves, CA Morris, PJ Hart &amp; AR Urbach (2011) Molecular recognition of insulin by a synthetic receptor. Journal of the American Chemical Society 133, 8810-8813.</li>
<li>G Grigoryan, YH Kim, R Acharya, K Axelrod, RM Jain, L Willis, M Drndic, JM Kikkawa &amp; WF DeGrado (2011) Computational design of virus-like protein assemblies on carbon nanotube surfaces. Science 332, 1071-1076.</li>
<li>3cyu: JA Aaron, JM Chambers, KM Jude, L Di Costanzo, IJ Dmochowski &amp; DW Christianson (2008) Structure of a 129Xe-cryptophane biosensor complexed with human carbonic anhydrase II. Journal of the American Chemical Society 130, 6942-6943.</li>
<li>MM Spence, SM Rubin, IE Dimitrov, EJ Ruiz, DE Wemmer, A Pines, SQ Yao, F Tian &amp; PG Schultz (2001) Functionalized xenon as a biosensor. Proceedings of the National Academy of Science USA  98, 10654-10657.</li>
<li>J Baggott (1996) Perfect symmetry – The accidental discovery of buckminsterfullerene. Oxford University Press.</li>
</ol>
</div>
</div>
<hr class="motm-hr"/>
<p>June 2018, Luigi Di Costanzo &amp; David Goodsell</p> <a href="http://doi.org/10.2210/rcsb_pdb/mom_2018_6">http://doi.org/10.2210/rcsb_pdb/mom_2018_6</a>
</div>
<div class="row hidden-print" style="margin-top:20px;">
<div class="col-xs-12">
<div class="panel panel-info">
<div class="panel-heading">About Molecule of the Month</div>
<div class="panel-body"><small>
                   
                  The RCSB PDB Molecule of the Month by David S. Goodsell (The Scripps Research Institute and the RCSB PDB) presents short accounts on selected molecules from the Protein Data Bank. Each installment includes an introduction to the structure and function of the molecule, a discussion of the relevance of the molecule to human health and welfare, and suggestions for how visitors might view these structures and access further details.<a href="https://pdb101.rcsb.org/motm/motm-about">More</a></small>
</div>
</div>
</div>
</div>
<script>
          $('#iframe').load(function () {
              $(this).height($(this).contents().find('body').height() + 30);
          });
        </script>
</div>
</body>
</html>
